1. Home
  2. ABVX vs METC Comparison

ABVX vs METC Comparison

Compare ABVX & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • METC
  • Stock Information
  • Founded
  • ABVX 2013
  • METC 2015
  • Country
  • ABVX France
  • METC United States
  • Employees
  • ABVX N/A
  • METC N/A
  • Industry
  • ABVX
  • METC Coal Mining
  • Sector
  • ABVX
  • METC Energy
  • Exchange
  • ABVX Nasdaq
  • METC Nasdaq
  • Market Cap
  • ABVX 722.3M
  • METC 618.9M
  • IPO Year
  • ABVX N/A
  • METC 2017
  • Fundamental
  • Price
  • ABVX $9.50
  • METC $12.15
  • Analyst Decision
  • ABVX Strong Buy
  • METC Strong Buy
  • Analyst Count
  • ABVX 6
  • METC 3
  • Target Price
  • ABVX $36.50
  • METC $19.67
  • AVG Volume (30 Days)
  • ABVX 82.3K
  • METC 538.3K
  • Earning Date
  • ABVX 09-09-2024
  • METC 11-04-2024
  • Dividend Yield
  • ABVX N/A
  • METC 4.54%
  • EPS Growth
  • ABVX N/A
  • METC N/A
  • EPS
  • ABVX N/A
  • METC 0.71
  • Revenue
  • ABVX $9,676,417.00
  • METC $698,132,000.00
  • Revenue This Year
  • ABVX $31.67
  • METC N/A
  • Revenue Next Year
  • ABVX $1,189.66
  • METC $25.55
  • P/E Ratio
  • ABVX N/A
  • METC $17.02
  • Revenue Growth
  • ABVX 100.87
  • METC 11.52
  • 52 Week Low
  • ABVX $8.75
  • METC $9.03
  • 52 Week High
  • ABVX $17.02
  • METC $22.70
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 34.50
  • METC 58.88
  • Support Level
  • ABVX $10.27
  • METC $11.78
  • Resistance Level
  • ABVX $10.79
  • METC $12.82
  • Average True Range (ATR)
  • ABVX 0.36
  • METC 0.60
  • MACD
  • ABVX -0.05
  • METC 0.18
  • Stochastic Oscillator
  • ABVX 8.16
  • METC 79.32

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves and resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mill and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

Share on Social Networks: